Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
11/20/2013 | CN103403020A Novel alkali-resistant variants of protein a and their use in affinity chromatography |
11/20/2013 | CN103403019A Engineered polypeptides having enhanced duration of action |
11/20/2013 | CN103402550A HER2 binding peptides labelled with a 18F - containing organosilicon compound |
11/20/2013 | CN103402546A Hydrophobic modified peptides for liver specific diagnosis |
11/20/2013 | CN103402545A Hydrophobic modified peptides and their use for liver specific targeting |
11/20/2013 | CN103402542A Medicinal agent for inhibiting metastasis of malignant tumor |
11/20/2013 | CN103402533A Use of amino acid sequences from mycobacterium tuberculosis or corresponding nucleic acids for diagnosis and prevention of tubercular infection, diagnostic kit and vaccine therefrom. |
11/20/2013 | CN103397050A Preparation of organisms with faster growth and/or higher yield |
11/20/2013 | CN103397041A Cytolethal distending toxinand detection of campylobacter bacteria with cytolethal distending toxin as target |
11/20/2013 | CN103397040A Recombinant plant-derived antihypertensive peptide |
11/20/2013 | CN103397039A Clone and application of nonexpressor of pathogenesis-related genes 1(NPR1) of morus alba var.multicaulis |
11/20/2013 | CN103397038A Production method of human interleukin-38 |
11/20/2013 | CN103396998A Recombinant co-expression of vitamin k epoxide reductase subunit 1 to improve vitamin k dependent protein expression |
11/20/2013 | CN103396494A Monoclonal antibody of blood coagulation factor IX |
11/20/2013 | CN103396479A Method for purification of alpha-1-antitrypsin and apolipoprotein A-I |
11/20/2013 | CN103396478A Recombinant N-glycosylated protein from procaryotic cell |
11/20/2013 | CN103396477A Protein related to plant potassium ion absorption capacity, and coding gent and application thereof |
11/20/2013 | CN103396474A APJ receptor compound |
11/20/2013 | CN103394076A Process for preparing human serum albumin |
11/20/2013 | CN102924582B Plant-adversity-resistance related protein TaNAC67 as well as coding gene and application thereof |
11/20/2013 | CN102757491B Method for recycling water-soluble proteins in minced fish rinsing water |
11/20/2013 | CN102675434B Magnaporthe oryzae isolated protein for improving plant resistance and inducing defense reaction of plant and gene and application of magnaporthe oryzae isolated protein |
11/20/2013 | CN102603888B Human relaxin 2 precursor and preparation method thereof |
11/20/2013 | CN102584980B Interferon alpha mutant and polyethylene glycol derivative thereof |
11/20/2013 | CN102532304B Preparation method of human serum albumin |
11/20/2013 | CN102363633B Glucagon like peptide-1 mutant polypeptide and preparation method, medicinal composition and use thereof |
11/20/2013 | CN102296075B Gene causing paroxysmal kinesigenic dyskinesia (PKD) |
11/20/2013 | CN102206639B Gene adjusting starch anabolism of plant seeds and application thereof |
11/20/2013 | CN101951939B Pegylation by the dock and lock (DNL) technique |
11/20/2013 | CN101812126B Novel HLA-A2 restrictive epitope polypeptide coming from hPEBP4 protein and application thereof |
11/20/2013 | CN101797382B Anti-human progastrin polypeptide immune composition |
11/20/2013 | CN101648996B Anti-myocardial remodelling polypeptide, preparation method thereof, preparations and application thereof in preparation of anti-myocardial remodelling medicament |
11/20/2013 | CN101376673B Rice fat synthesis related gene and use thereof |
11/20/2013 | CN101367872B Protein-polymer conjugates |
11/19/2013 | US8586830 Ioslated TT1 polynucleotide, encoded proteins and vectors for increasing tolerance of plants and microbes to abiotic stresses and the use thereof |
11/19/2013 | US8586826 Virus vector and use thereof |
11/19/2013 | US8586722 Methods of using tubers having genetically modified potato plant cells |
11/19/2013 | US8586717 Method for the diagnosis and prognosis of malignant diseases |
11/19/2013 | US8586711 Polymer-factor IX moiety conjugates |
11/19/2013 | US8586710 Process for gram scale production of PEG-r-metHuG-CSF |
11/19/2013 | US8586708 Monovalent streptavidin compositions |
11/19/2013 | US8586540 Composition for improving skin conditions using fetal mesenchymal stem cells from amniotic fluid |
11/19/2013 | US8586538 Method of treating a patient suffering from a bleeding disorder comprising administering an antibody against the A3-C1 of FVIII |
11/19/2013 | US8586534 Intracellular domain of a mammalian Fat1 (Fat1IC) |
11/19/2013 | US8586532 Method for selectively modifying a protein via transglutaminase catalyzed reaction |
11/19/2013 | US8586530 Modulation of inhibition of ferrochelatase by N-methyl protoporphyrin |
11/19/2013 | US8586386 Peptide or protein comprising a C′-D loop of the CD28 receptor family |
11/19/2013 | US8586355 Embryo sac-specific genes |
11/19/2013 | US8586345 Electroprocessed collagen and tissue engineering |
11/19/2013 | US8586328 Method for producing sclareol |
11/19/2013 | US8586327 Detection of bacteria belonging to the genus Campylobacter by targeting cytolethal distending toxin |
11/19/2013 | US8586317 Methods of diagnosing hypophosphatemic disorders |
11/19/2013 | US8586314 Peptide nucleic acid probes for detection, identification and/or quantitation of Pseudomonas (sensu stricto) |
11/19/2013 | US8586298 Methods and kits for diagnosing and treating b-cell chronic lymphocytic leukemia |
11/19/2013 | US8586291 Mutations in the Bcr-Abl tyrosine kinase associated with resistance to ST1-571 |
11/19/2013 | US8586057 Enterohemorrhagic Escherichia coli vaccine |
11/19/2013 | US8586047 Genetic products differentially expressed in tumors and the use thereof |
11/19/2013 | US8586034 Cytomegalovirus disintegrin-like peptides |
11/19/2013 | CA2707235C Recombinant influenza virus-like particles (vlps) produced in transgenic plants expressing hemagglutinin |
11/19/2013 | CA2703533C Polynucleotides and methods for making plants resistant to fungal pathogens |
11/19/2013 | CA2599059C Process for making a low molecular weight gelatine hydrolysate and gelatine hydrolysate compositions |
11/19/2013 | CA2593520C Recombinant expression of proteins in a disulfide-bridged, two-chain form |
11/19/2013 | CA2573780C Recombinant spider silk proteins |
11/19/2013 | CA2554966C Methods and compostions for targeted cleavage and recombination |
11/19/2013 | CA2502636C Diagnosis of shwachman-diamond syndrome |
11/19/2013 | CA2496213C Metalloprotease activation of myostatin, and methods of modulating myostatin activity |
11/19/2013 | CA2486450C Chimaeric human papillomavirus 16 l1 virus-like particles and method for preparing the particles |
11/19/2013 | CA2473987C Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases |
11/19/2013 | CA2442684C Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors |
11/19/2013 | CA2434845C Hepatitis c virus replicons and replicon enhanced cells |
11/19/2013 | CA2425842C Use of il-1 inhibitors and tnf antagonists, partially in combination with recombinant erythropoietins, for the treatment of anemia |
11/19/2013 | CA2411694C Furin polypeptides with improved characteristics |
11/19/2013 | CA2398083C Nphs2 gene involved in the cortico-resistant neprhotic syndrome, protein encoded by said gene and diagnostic and therapeutic uses |
11/19/2013 | CA2383217C Lysosomal targeting pathway enzymes |
11/19/2013 | CA2375800C Vaccine against isa virus |
11/19/2013 | CA2353866C Treatment of papillomavirus infections |
11/19/2013 | CA2346996C Dimeric thrombopoietin peptide mimetics binding to mp1 receptor and having thrombopoietic activity |
11/19/2013 | CA2305620C Method for the covalent attachment of polysaccharides to protein molecules |
11/19/2013 | CA2290220C An infectious cdna clone of north american porcine reproductive and respiratory syndrome (prrs) virus and uses thereof |
11/14/2013 | WO2013170050A1 Engineered imine reductases and methods for the reductive amination of ketone and amine compounds |
11/14/2013 | WO2013169929A1 Reducing immunogenicity of xenogeneic transplant tissues |
11/14/2013 | WO2013169382A1 Methods and devices for treating intervertebral disc disease |
11/14/2013 | WO2013169102A1 A bacteriophage for biocontrol of salmonella and in the manufacturing or processing of foods |
11/14/2013 | WO2013168602A1 Method for detecting disseminated intravascular coagulation or infectious disseminated intravascular coagulation |
11/14/2013 | WO2013168181A1 Polynucleotide encoding catlp1 protein and uses thereof |
11/14/2013 | WO2013168178A1 Process for renaturation of polypeptides |
11/14/2013 | WO2013168164A1 Variants of tace pro-domain as tnf-a inhibitor and their medical use |
11/14/2013 | WO2013167574A1 Anti-inflammatory peptides and composition comprising the same |
11/14/2013 | WO2013167471A1 Artificial forisome body with seo-f fusion proteins, plant or yeast cells comprising vectors which code for these proteins, as well as vectors which code for seo-f fusion proteins |
11/14/2013 | WO2013167455A1 Double-acylated glp-1 derivatives |
11/14/2013 | WO2013167454A1 Double-acylated glp-1 derivatives |
11/14/2013 | WO2013167299A1 Anti-inflammatory peptides and composition comprising the same |
11/14/2013 | WO2013167298A1 Anti-inflammatory peptides and composition comprising the same |
11/14/2013 | WO2013166996A1 Gene improving the stress resistance of plants and use thereof |
11/14/2013 | WO2013166609A1 Rotavirus-like particle production in plants |
11/14/2013 | WO2013166585A1 Detection and recovery of chemical elements from fluids with tectrabrachion |
11/14/2013 | WO2013166555A1 Methods of treating cancer using angiogenin or an angiogenin agonist |
11/14/2013 | WO2013144345A3 Toll-like receptor 2 binding epitope and binding members thereto |
11/14/2013 | WO2013136057A3 Genes involved in noscapine production |
11/14/2013 | WO2013093760A3 Compositions, methods, and kits for preparing sialylated recombinant proteins |